Keywords: Prostate, Prostate
Motivation: Prostate specific antigen(PSA) and PSA density (PSAD) are inadequate for PCa screening.
Goal(s): Our goal was to combine PSA and MRI measures from Hybrid Multi-dimensional MRI (HM-MRI) to improved PCa diagnosis.
Approach: Blood PSA level, prostate volume from mpMRI and tissue volumes (epithelium, lumen) from HM-MRI were used to measure PSAD and PSAD normalized by tissue type (nPSAD).
Results: nPSADepithelium is significantly lower and nPSADlumen is significantly higher in cancer patients compared to benign subjects. The diagnostic accuracy of nPSAD to detect subjects with PCa, was significantly higher than conventional PSAD, and further improved by combining nPSAD with tissue composition measures from HM-MRI.
Impact: We introduce a new cancer biomarker that combines PSA (blood-based biomarker) with tissue composition from HM-MRI. nPSADlumen and nPSADepithelium improve PCa diagnosis. These new biomarkers may signal effects of PCa on normal prostate and may indicate cancer aggressiveness.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords